Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
FEATURED NOTICE | |
Port of Bremerton Airport Feasibility Study | |
New Bid Calls | 9 |
New Consultant Notices | 3 |
New Supply Bids | 0 |
WILBURTON INSTRUCTIONAL SERVICE CENTER BELLEVUE SCHOOL DISTRICT Kassel & Associates |
HOWARD A. HANSON DAM ADDITIONAL WATER STORAGE PROJECT – FISH PASSAGE SOLICITATION NO: W912DW24R0004 Kiewit Infrastructure West Co. |
RESERVOIR 3 REPLACEMENT, PHASE 1 Walsh Construction Company II, LLC |
CITY HALL ADDITION & MODERNIZATION - CITY OF BUCKLEY Kassel & Associates |
POST IAF AIRLINE REALIGNMENT, MC/ CM BID PACKAGE #1 (CONTROLS, INSULATION) Shinn Mechanical Inc. |
more » |
print email to a friend reprints add to mydjc |
March 24, 2020
Seattle-based private biopharmaceutical company Silverback Therapeutics raised $78.5 million in Series B funding and brought on Dr. Jonathan Root and Dr. Thilo Schroeder as board members. U.S. Venture Partners led the financing round, with participation from Nextech Invest, Hunt Investment Group, Pontifax Venture Capital, Colt Ventures, NS Investment, OrbiMed Advisors, Bristol-Meyers Squibb and Alexandria Venture Investments. Root is a general partner at U.S. Venture Partners and Schroeder is a partner at Nextech. Silverback is developing ways to eradicate solid tumors.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2024 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index